- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02388256
Acupuncture for Enhanced Recovery After Surgery in Patients Undergoing Laparoscopic Colorectal Cancer Resection
Background:
Patients who undergo laparoscopic surgical resection of colorectal cancer may experience various post-operative symptoms (e.g., pain, nausea and vomiting, and anxiety) and limitation of daily activities (e.g., walking capacity). There is also a risk of post-operative complications and a prolonged hospital stay due to complications. Patients who underwent surgical resection may have experienced chronic pain, anxiety/depression, or diminished quality of life. The physical, psychological, and functional aspects of patients' disorders imply the necessity of multidisciplinary care, including complementary or traditional medicines such as acupuncture. This study aims to assess whether acupuncture treatment, combined with an enhanced recovery program after surgery in an inpatient care setting is effective than only an enhanced recovery program after surgery.
Objective:
To assess the effectiveness and safety of acupuncture combined with an enhanced recovery program after surgery to reduce postoperative symptoms and improve functional recovery and the patients' quality of life.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Kyung Sang South Province
-
Yangsan, Kyung Sang South Province, Korea, Republic of, 626770
- National Clinical Research Centre for Korean Medicine, Korean Medicine Hospital, Pusan National University
-
Yangsan, Kyung Sang South Province, Korea, Republic of, 626770
- Pusan National University Yangsan Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients undergoing elective laparoscopic surgery of colorectal cancer resection (right hemicolectomy, left hemicolectomy, anterior resection with primary anastomosis, and low anterior resection with loop ileostomy for fecal diversion)
- Patients aged 18 to 75
- American Society of Anesthesiologists Grade 1 to 2
- Eastern Cooperative Oncology Group Grade 0 to 2
- Written informed consents
Exclusion Criteria:
- Pregnancy
- Inflammatory bowel disease
- Comorbidities that may affect outcomes of surgery (e.g., chronic kidney disease, chronic liver disease, cardiopulmonary failure, and diabetes with complications)
- Resection of other organs for radical removal of colorectal cancer
- Patients requiring enterolysis due to previous history of abdominal surgery
- Obstructive colorectal cancer
- Metastatic colorectal cancer
- Cognitive impairment that may affect the patient's ability to complete the outcome assessments
- Previous history of stroke
- Previous history of sensitive reaction to acupuncture
- Patients unable to cooperate with acupuncture treatments
- Pacemaker implantation
- Previous history of epilepsy
- Patients who have received Korean medicine treatments (acupuncture, moxibustion, cupping, or herbal medicine) within 2 weeks
- Patients who have participated in other trials within 3 months
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Acupuncture
Manual and electroacupuncture
|
Points of Stomach 36 (ST36), Stomach 37 (ST37), Liver 3 (LR3), Large Intestine 11 (LI11), Large Intestine 4 (LI4), Spleen 6 (SP6), Spleen 4 (SP4) and Pericardium 6 (PC6) will be used. Electrical stimulation with alternating frequency of 2 to 100 Hz will be applied to the selected points (LI4 to LI11, ST36 to ST37, and bilateral SP6). Rationale of acupuncture treatments will include both traditional theory of harmonizing gastrointestinal function and strengthening vital energy as well as modern experimental and clinical evidence of regulating gastrointestinal motility and other symptom managements. Treatments will be provided by qualified hospital staff (Korean medical doctors) with more than 10 years of clinical experience. |
|
Active Comparator: Enhanced recovery program after surgery
|
Points of Stomach 36 (ST36), Stomach 37 (ST37), Liver 3 (LR3), Large Intestine 11 (LI11), Large Intestine 4 (LI4), Spleen 6 (SP6), Spleen 4 (SP4) and Pericardium 6 (PC6) will be used. Electrical stimulation with alternating frequency of 2 to 100 Hz will be applied to the selected points (LI4 to LI11, ST36 to ST37, and bilateral SP6). Rationale of acupuncture treatments will include both traditional theory of harmonizing gastrointestinal function and strengthening vital energy as well as modern experimental and clinical evidence of regulating gastrointestinal motility and other symptom managements. Treatments will be provided by qualified hospital staff (Korean medical doctors) with more than 10 years of clinical experience.
An enhanced recovery program after surgery that was designed and is currently implemented by surgeons, anesthetists, dietitians, and nurses will be provided.
The program includes preoperative education, early water/food intake, early mobilization, early removal of Foley catheter and drains, structured nursing care, and nutritional support.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Recovery of physical function
Time Frame: at 2 weeks after surgery
|
Recovery of physical function, as measured by the physical function domain of European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ) C30 instrument
|
at 2 weeks after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain intensity
Time Frame: at 4, 12, 24, 48, 72 hours after surgery, at 1 week after surgery (an expected day of discharge), at 2 weeks after surgery, and at 4 weeks after surgery
|
Pain scores on a numeric rating scale.
Score ranges from 0 (no pain at all) to 10 (the worst pain imaginable)
|
at 4, 12, 24, 48, 72 hours after surgery, at 1 week after surgery (an expected day of discharge), at 2 weeks after surgery, and at 4 weeks after surgery
|
|
Time to first flatus
Time Frame: up to 1 week after surgery (an expected period of admission)
|
elapsed time after surgery
|
up to 1 week after surgery (an expected period of admission)
|
|
Time to tolerate soft diet
Time Frame: up to 1 week after surgery (an expected period of admission)
|
elapsed time after surgery
|
up to 1 week after surgery (an expected period of admission)
|
|
Time to first defecation
Time Frame: up to 1 week after surgery (an expected period of admission)
|
elapsed time after surgery
|
up to 1 week after surgery (an expected period of admission)
|
|
Time to independent walk
Time Frame: up to 1 week after surgery (an expected period of admission)
|
elapsed time after surgery
|
up to 1 week after surgery (an expected period of admission)
|
|
Number of insertions of nasogastric tube
Time Frame: up to 1 week after surgery (an expected period of admission)
|
number of insertions of nasogastric tube
|
up to 1 week after surgery (an expected period of admission)
|
|
Incidence of nausea/vomiting
Time Frame: up to 1 week after surgery (an expected period of admission)
|
number of nausea / vomiting reported by the patients
|
up to 1 week after surgery (an expected period of admission)
|
|
Time to first removal of Foley catheter
Time Frame: up to 1 week after surgery (an expected period of admission)
|
elapsed time after surgery
|
up to 1 week after surgery (an expected period of admission)
|
|
Number of reinsertions of Foley catheter
Time Frame: up to 1 week after surgery (an expected period of admission)
|
number of reinsertions of Foley catheter
|
up to 1 week after surgery (an expected period of admission)
|
|
Number of clean intermittent catheterizations
Time Frame: up to 1 week after surgery (an expected period of admission)
|
number of clean intermittent catheterizations
|
up to 1 week after surgery (an expected period of admission)
|
|
Quality of life measured by EORTC QLQ C30
Time Frame: at 2 weeks after surgery, at 4 weeks after surgery, and at 12 weeks after surgery
|
Quality of life measured by EORTC QLQ C30
|
at 2 weeks after surgery, at 4 weeks after surgery, and at 12 weeks after surgery
|
|
Patient's global assessment after surgery
Time Frame: at 4 weeks after surgery, at 12 weeks after surgery
|
Response options include very much improved, somewhat improved, no change, somewhat worsened, and very much worsened.
|
at 4 weeks after surgery, at 12 weeks after surgery
|
|
Use of medication
Time Frame: at 1 week after surgery (an expected day of discharge), at 2 weeks after surgery, at 4 weeks after surgery, and at 12 weeks after surgery
|
Use of analgesics, antiemetics and other medications after surgery
|
at 1 week after surgery (an expected day of discharge), at 2 weeks after surgery, at 4 weeks after surgery, and at 12 weeks after surgery
|
|
Anxiety and depression
Time Frame: at 2 weeks after surgery, at 4 weeks after surgery, at 12 weeks after surgery
|
Patients' anxiety and depression level measured by the Hospital Anxiety-Depression Scale
|
at 2 weeks after surgery, at 4 weeks after surgery, at 12 weeks after surgery
|
|
Postoperative complications
Time Frame: within 12 weeks after surgery
|
|
within 12 weeks after surgery
|
|
Serious adverse events
Time Frame: within 12 weeks after surgery
|
|
within 12 weeks after surgery
|
|
Adverse events related to acupuncture
Time Frame: within 12 weeks after surgery
|
Expected or unexpected adverse events that are considered to be associated with acupuncture treatments.
|
within 12 weeks after surgery
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adherence to enhanced recovery program after surgery
Time Frame: at 1 week after surgery (an expected day of discharge)
|
Number of patients who discharge the hospital at the expected day as planned
|
at 1 week after surgery (an expected day of discharge)
|
Collaborators and Investigators
Investigators
- Principal Investigator: Gi Young Yang, PhD, Korean Medicine Hospital, Pusan National University
- Principal Investigator: Kyung Mo Son, PhD, Pusan National University Yangsan Hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 03-2014-012
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.